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Abstract
Background: The past years have seen the development of many synthetic bone replacements.
To test their biocompatibility and ability for osseointegration, osseoinduction and -conduction
requires their placement within bone preferably in an animal experiment of a higher species.
Methods: A suitable experimental animal model in sheep with drill holes of 8 mm diameter and
13 mm depth within the proximal and distal humerus and femur for testing biocompatibility issues
is introduced.
Results: This present sheep model allows the placing of up to 8 different test materials within one
animal and because of the standardization of the bone defect, routine evaluation by means of
histomorphometry is easily conducted. This method was used successfully in 66 White Alpine
Sheep. When the drill holes were correctly placed no complications such as spontaneous fractures
were encountered.
Conclusion:  This experimental animal model serves an excellent basis for testing the
biocompatibility of novel biomaterials to be used as bone replacement or new bone formation
enhancing materials.
Background
The use of resorbable and non- resorbable biomaterials,
such as hydroxyapatite or tricalcium phosphate, as syn-
thetic bone replacements is well established in orthopae-
dic, maxillofacial and dental surgery [1,2]. Although
autologous cancellous bone is the material of choice for
bone replacement and induction there are limitations in
relation to its use, such as limited amount of material,
additional surgical procedure, prolonged surgery and
complications of wound healing at the donor site.
Because of this there is continuous interest in the develop-
ment of new synthetic materials [3-5].
The most important aspect in the development of new
(biodegradable) biomaterials is the experimental and
clinical testing for biocompatibility [6-8]. This is closely
followed by the bioactivity, which relates to the resorp-
tion or integration of the implanted material into the sur-
rounding bone, also called "osseointegration" and the
ability to initiate and support the apposition and integra-
tion of the new bone, in particular in comparison with
previously established materials [4].
Various animal species are used for these biocompatibility
tests, such as the mouse [9], rat [10-18], guinea pig [19],
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rabbit [20-23], dog [24-28] goat [29] and sheep [30-32].
Furthermore, different implantation sites and methods
have been used to examine biocompatibility issues.
Among them are intra-peritoneal [13], subcutaneous
[12,14,17,33], intraosseous such as in the mandible
[19,27], femur [11,15,24,25]), tibia [18,20,21,23,26,30],
cranial bone [28,31] and intramuscular [9,16,29] applica-
tions.
The use of sheep for orthopaedic research continues to
increase. This is due to the similarities with humans in
weight, bone and joint structure and bone regeneration
[34-36]. Although rodents may be less expensive, they
have different bone morphology. Another practical reason
is that rodents often are too small in size to test degrada-
ble materials in bone especially in combination with
internal fixation and fracture repair [37,38]. Furthermore,
the influence of the different mechanical properties of
bone from different species awaits clarification in relation
to the outcome of these studies [39,40].
To contribute to the standardisation of testing new and
biodegradable materials for use in orthopaedics, maxillo-
facial and dental surgery our research group has devel-
oped an animal model with sheep that allows the
intraosseous implantation of 8 different samples per
sheep in long bones [41,42]. This animal model facilitates
testing inter- and intra-individual differences among dif-
ferent materials while at the same time reducing overall
suffering of animals as well as necessary numbers to sat-
isfy statistical requirements. It has been already success-
fully applied for several studies related to testing
biodegradable materials [32] and to the knowledge of the
authors has never been described before in the literature.
Methods
Instruments
In addition to routine surgical instruments, Weitlaner and
Gelpi-retractors, a periosteal elevator, pneumatic drill
(Synthes, Waldenburg, Switzerland) with an 8 mm,
slightly modified drill bit (KaVo INTrASurg 500®, KaVo
Dental AG Biberach, Germany, modified by Synthes, Wal-
denburg, Switzerland) and a corresponding drill guide
were used (Fig. 1). The drill bit was modified with a spe-
cial depth-regulating device and the tip was flattened
while still having good cutting characteristics.
Biomaterials
Implanted were various cements (β-tricalciumphos-
phates, brushite, hydroxyapatite), hydrogels (fibrin-
based, polyethylene glycol) and other resorbable or non-
resorbable bone replacement materials as composites
with or without growth factors such as parathyroid hor-
mone (PTH1–34), bone morphogenic protein (BMP-2),
transforming growth factor (TGFβ) and insulin-like
growth factor 1 (IGF-1).
Experimental animals
Used were 70 healthy ewes, White Swiss Alpine Sheep,
with an age of 2 to 5 years and a bodyweight of 53 to 80
kg. The implantation sites were the proximal part of the
diaphysis and distal epiphysis of humerus and femur (Fig.
2). This provided a total of 8 implant sites per animal. All
animal experiments were carried out according to the
Swiss Laws of animal welfare and were approved by the
Ethics Commission of the official veterinary authorities
(Authorisation Numbers: 53/2000, 139/2000, 09/2002,
176/2003, 118/2004, 14/2005, 15/2005, 90/2005).
The experimental animals were kept in stalls prior to sur-
gery. Food was withdrawn 36 hours, and water 6 hours
prior to anaesthesia. A pre-anaesthetic examination was
performed including haematology and a chemscreen con-
sisting of liver enzymes, urea, creatinine, protein, albu-
min, sodium and potassium. After recovery of the animals
from anaesthesia, they were initially kept in small groups
The photograph shows the 8 mm special depth-regulating bit  and corresponding drill guide (la) and the close-up (lb) the  flattened tip of the drill bit Figure 1
The photograph shows the 8 mm special depth-regulating bit 
and corresponding drill guide (la) and the close-up (lb) the 
flattened tip of the drill bit.
a
bBMC Musculoskeletal Disorders 2006, 7:67 http://www.biomedcentral.com/1471-2474/7/67
Page 3 of 14
(page number not for citation purposes)
in stables. After 10 days, the skin staples were removed
and the animals were allowed to join the flock on the
fields normally at 20 days after surgery. They were checked
daily for lameness and additional clinical problems. Food
and water were given ad libitum.
Surgery
Animals were sedated with medetomidine (5 µg/kg BW,
Domitor™, Orion Pharma Animal Health, Finland) and
anaesthesia was induced with ketamine (2 mg/kg BW,
Narketan® 10, Chassot GmbH, Germany) in combination
with diazepam (0.01 mg/kg BW, Valium®, Roche, Switzer-
land) and maintained with 0.8 Vol% isoflurane (Forene®,
Abbot AG, Switzerland) in O2 and an infusion of Ringer's
solution with 60 mg ketamine (Narketan™ 10, Chassot
GmbH, Germany)/litre at a rate of 10 ml/kg BW/hour.
The animals received as pre-and post-operative prophy-
laxis 30,000 IU penicillin/kg BW (Hoechst AG, Germany)
and 6 mg gentamicin/kg BW (Streuli & Co AG, Switzer-
land) intravenously twice a day. In addition, they received
subcutaneously 500 Units of equine tetanus serum as a
single application (Tetanus Serum Veterinaria AG, Zurich,
Switzerland).
Analgesia was maintained through injection of 0.01 mg
buprenorphine/kg BW i.v. perioperatively and addition-
ally 4 mg carprofen/kg BW i.v. (Rimadyl®, Pfizer Inc., NY,
USA) postoperatively for 3 days. The area in the region of
the incisions was clipped and disinfected in the standard
manner.
The animals were placed in left or right lateral recum-
bency on the operating table with the limbs placed in a
horizontal position. The approach to the bone was always
from the lateral side (Fig. 2). It is important for the fore-
limb that the humerus is positioned parallel with the
humeral condyles being at a 90° angle to the surgery
table. Furthermore the limb should be slightly flexed to
the position that the lateral epicondyle of the humeral
condyle can be palpated easily directly under the skin. The
hind limb should be also slightly flexed such that the lat-
eral collateral ligament can be palpated through the skin,
although a slight downward inclination of the hind limb
may facilitate access to the proximal femur. Both, the fore-
and hind limbs should be additionally supported from
underneath so that they cannot be pushed down when
drilling the hole but remain stable in the prepared plane.
With all approaches an attempt was made to keep the skin
incisions and preparation of soft tissue down to the bone
as small as possible (ca. 6–8 cm in length). To facilitate
the further surgical approaches to all locations, the
wounds were kept open by means of either a Weitlaner
retractor alone or in combination with a Gelpi retractor
that was usually placed perpendicular to the already
placed Weitlaner retractor (proximal and distal femur).
The periosteal elevator was used to prepare the location of
the drill hole such that all overlying soft tissues were
removed from the bone. This facilitated the placement of
the drill guide and avoided the slippage of the drill bit ini-
tially before the drill had started to penetrate the cortical
bone. The description of the four different surgical sites is
given below. A total number of 560 drill holes were placed
(n = 560 with 70 drill holes in each location). Immedi-
ately after drilling, the holes were filled with the various
test materials. After filling the drill holes, the different
wound layers as described in the approaches were closed
separately with non-resorbable suture material (Vicryl 2/
0, Johnson & Johnson, Brussels, Belgium) and the skin
was stapled (Davis and Geck Appose ULCr, B. Braun Aes-
culap AG, Tuttlingen, Germany)
Approaches
Proximal part of humeral diaphysis (Fig. 3)
The skin incision began at the level of the acromion and
followed a slightly curved line over the shoulder joint to
the middle of the proximal third of the humerus (Fig. 3a).
After dissecting the subcutaneous fascia the acromial part
of the deltoid muscle was visible and situated between the
trapezius and the omotransversarius muscles. These mus-
cles were then retracted caudally (Fig. 3b). Beneath
appeared the tendon of insertion of the infraspinatus
muscle. A hole was then drilled into the humerus caudally
to this tendon and in the medial direction. A small vessel
without a given name of less than 1 mm in diameter and
Layout of the approaches to the implantation sites: the dot- ted lines represent the sites of skin incisions Figure 2
Layout of the approaches to the implantation sites: the dot-
ted lines represent the sites of skin incisions.BMC Musculoskeletal Disorders 2006, 7:67 http://www.biomedcentral.com/1471-2474/7/67
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Surgical procedure at the proximal diaphysis of the humerus: The skin incision extends from the acromion to the distal end of  the tuberculum majus (Fig. 3a) Figure 3
Surgical procedure at the proximal diaphysis of the humerus: The skin incision extends from the acromion to the distal end of 
the tuberculum majus (Fig. 3a). The acromial part of the deltoid muscle is dislocated caudally to expose the tendon of insertion 
of the infraspinatus muscle (Fig. 3b), where the hole is drilled caudally to the insertion point and distally to the unnamed vessel 
(arrow) (Fig. 3c).
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crossing the bone directly above the insertion of the ten-
don served as a consistent landmark (Fig. 3c).
Distal epiphysis of the humerus (Fig. 4)
A slightly curved skin incision was made laterally, directly
over the lateral epicondyle of the humerus (Fig. 4a). After
the dissecting of the subcutaneous and deep fasciae the
lateral epicondyle giving origin to the lateral collateral lig-
ament could be palpated. An incision was made in the lig-
ament paralleling the direction of its fibres (Fig. 4b). The
drill guide was passed through the opening and the drill
hole situated exactly in the centre of the groove and the
lateral humeral condyle (Fig. 4c).
Proximal part of the femoral diaphysis (Fig. 5)
The skin incision was made directly above the easily pal-
pable greater trochanter of the femur (Fig. 5a). The medial
gluteal muscle appeared immediately after the incision of
the subcutaneous fascia. The muscle was penetrated in a
longitudinal direction using a blunt incision (Fig. 5b).
The underlying fascia lata was opened with a scalpel blade
exposing the lateral vastus of the quadriceps muscle (Fig.
5c). The access to the bone was then made directly
beneath the greater trochanter through a longitudinal
incision of the lateral vastus of the quadriceps muscle (Fig.
5d). The drill guide was placed perpendicular to the bone
axis and firmly pressed to the bone to avoid slippage dur-
ing drilling. It was located 1.5 cm below the tip at the base
and in the centre of the greater trochanter (Fig. 5e).
Distal epiphysis of the femur (Fig. 6)
Palpable bone landmarks are the patella, the tibial tuber-
osity and the lateral condyles of the femur. The skin inci-
sion was performed in the triangle between the patella
and the tibial tuberosity on the one and the lateral con-
dyles of femur and tibia on the other side (Fig. 6a). With
the splitting of the subcutaneous fascia the aponeurosis of
the biceps muscle was visible. The muscle fascia was
opened with a small (ca. 2 cm) incision perpendicular to
the muscle fibres (Fig. 6b) and the underlying muscle tis-
sue was bluntly dissected down to the lateral condyle of
the femur. The hole was drilled closely to the proximal
origin of the lateral collateral ligament of the stifle joint
(Fig 6c).
After surgery the exact locations of the material-filled
holes could be determined using radiographs (Figs. 7a
and 7b). Due to the different densities of the overlying
soft tissues (pelvis and proximal humerus versus elbow
and stifle joint), each radiograph had to be taken sepa-
rately amounting to 8 radiographs per animal. If radio-
graphic follow-ups had to be obtained at several time
intervals, each time the sheep had to be subjected to a
short anaesthesia (Sedation with medetomidine (5 µg/kg
BW, Domitor®, Orion Pharma Animal Health, Finland)
and induction with ketamine (2 mg/kg BW, Narketan® 10,
Chassot GmbH, Germany) in combination with
diazepam (0.01 mg/kg BW, Valium®, Roche, Switzerland)
and maintained with propofol (2–4 mg/kg BW, Diso-
privan® Astra Zeneca, Switzerland) to assure appropriate
quality of the radiographs.
Evaluation of samples
After the sheep were sacrificed both humeral and femoral
bones were harvested immediately, freed from all overly-
ing soft tissues and, if possible, the drill hole in the lateral
cortex was identified. Time points of sacrifice varied from
2, 4, 8, 16 to 24 weeks depending on the original study
question. The long bones were radiographed again using
a faxitron machine (Cabinet x-ray-faxitron series, model
43855A, Hewlett Packard®, USA) that allows visualizing
the detailed bone structure of the trabecular bone. There-
after, bone blocks were cut using a bone saw (K 410,
Kolbe GmbH, Elchingen, Germany) assuring a rim of at
least 3–4 mm of adjacent bone at the side and at the bot-
tom of the original bone defect. Care was taken that the
blocks were sectioned parallel to the original bone cylin-
der (Fig. 8). If important in relation to the original study
question (e.g. fine trabecular structure within bone defect
or adjacent bone) the blocks were radiographed again
with the faxitron machine (Fig. 9) or they were subjected
to micro-computed tomography. All samples were fixed
in either 4% paraformaldehyde or 10% fresh, buffered
formaldehyde, before they proceeded for histology of
non-decalcified bone section as described elsewhere
[42,43]. Briefly, after fixation, samples were washed in
buffered saline, dehydrated in a series of alcohol, defatted
in xylene under vacuum, infiltrated in methylmethacr-
ylate (methacrylacid-methylester; dibuthylphtalate and
perkadox in a proportion 89,5: 10: 0,5) and then finally
embedded in the same solution using special Teflon
molds placed in a standard water bath at 30°C. Ground
sections (30–40 µm) and thin sections (5 µm) were pre-
pared using special equipment (Leica® SP 1600 and Leica®
RM 2155; Leica Instruments GmbH, Nussloch, Germany).
Sections were either surface stained with toluidine blue in
case of ground sections, or deplastified with Methoxye-
thyl-acetate (Merck AG, Switzerland) and stained with
either toluidine blue or von Kossa/McNeil in case of thin
sections. Before mounting the ground sections to the opal,
acrylic Plexiglas slides (Wachendorf, Perspex GS, Acryl-
icglas Opal 1013) microradiographs were taken to visual-
ize the stage of calcification of the bone samples within
and adjacent to the biomaterial (Fig. 10). Sections were
cut in the middle of the bone defect and perpendicular to
the original drill hole revealing the round original bone
defect for further histological assessment with light micro-
scopy. Ground sections were used to determine resorption
of biomaterials, new bone formation and bone remodel-
ling of the adjacent bone, but also to measure the area andBMC Musculoskeletal Disorders 2006, 7:67 http://www.biomedcentral.com/1471-2474/7/67
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Surgical procedure at the distal epiphysis of the humerus: The skin incision is performed directly above the lateral epicondyle  of the humerus (Fig.4a) Figure 4
Surgical procedure at the distal epiphysis of the humerus: The skin incision is performed directly above the lateral epicondyle 
of the humerus (Fig. 4a). Then the proximal part of the Lig. collaterale laterale is incised with a scalpel following the direction 
of the fibres. The forceps tip is on the dorsal and prominent rim of a groove that gives origin to this ligament (Fig. 4b). The drill 
hole is situated directly in the centre of the groove between the fibres of the lateral collateral ligament (Fig. 4c).
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Surgical procedure at the proximal part of the femoral diaphysis: The skin incision is situated directly above the greater tro- chanter (Fig. 5a) Figure 5
Surgical procedure at the proximal part of the femoral diaphysis: The skin incision is situated directly above the greater tro-
chanter (Fig. 5a). The incision in the deep layer of the fascia lata reveales the medial gluteal muscle that is separated longitudi-
nally (Fig. 5b) to expose the lateral of the quadriceps muscle (Fig. 5c). The lateral vastus is split longitudinally (Fig. 5d) and the 
final drill hole is inserted in the centre at the base and 1.5 cm distally to the tip of the greater trochanter (Fig. 5e).
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Surgical procedure at the distal epiphysis of the femur: The skin incision extends between the lateral femoral condyle and the  tibial tuberosity of the tibia (Fig. 6a) Figure 6
Surgical procedure at the distal epiphysis of the femur: The skin incision extends between the lateral femoral condyle and the 
tibial tuberosity of the tibia (Fig. 6a). The incision in the aponeurosis of the biceps femoris muscle (Fig. 6b) is made perpendicu-
lar to the muscle fibres of the biceps femoris muscle and the drill hole is inserted just proximal to the origin of the lateral col-
lateral ligament of the stifle joint (Fig. 6c).
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percentage of bone, fibrous tissue and remnants of bio-
materials within the original defect by means of histomor-
phometry (Leica Qwin®, Leica Quips®, Leica, Glattbrugg,
Switzerland). For this, pictures were captured with the
macroscope as digital images in TIF-format (DC 200,
Leica. Glattbrugg, Switzerland) and at a 5.8 times magni-
fication. Thin sections were suitable for semi-quantitative
evaluation of samples with the light microscope (Leica,
DMR, Glattbrugg, Switzerland), where cellular reactions
were assessed based on a semi-quantitative score that was
specifically developed for each individual study [43].
Results
Anaesthesia and recovery phases were uneventful for 51 of
the 55 animals. As soon as the sheep were awake they
were placed in straw-lined small stalls. Ten days later, after
removal of the skin staples, animals were released to larger
stalls and finally were allowed to roam free on pasture
after 20 days. At no time did they show signs of lameness
or other discomfort.
For 4 sheep, the positioning of the drill holes was not
exactly in the correct places described above, but slightly
off towards the diaphysis of the femur or distal humerus
respectively. These animals suffered either from a commi-
nuted fractured humerus (n = 1) or femur (n = 3) within
the first 3 postoperative days. All four animals were imme-
diately euthanized after the complications occurred. All
other drill holes (total of n = 528 holes) could be easily
placed except in the distal humerus, where in 9 instances
the drill hole was initiated too far cranially and distally
resulting in slippage of the drill bit into the cranial pouch
of the elbow joint including an incomplete drill hole
within the cranial aspect of the lateral humeral condyle. In
those 9 instances, where initial slippage of the drill bit
occurred from the lateral humeral condylus, the surgeon
gave up drilling the hole to avoid spontaneous fractures of
the distal humerus. There, the biomaterials were never
applied.
After the pre-planned time period the animals were
slaughtered and the treated bones removed. Depending
on the time point of sacrifice the original drill hole was
easily detected or especially at later time points almost
healed, at least at the cortical site. But even then, there was
a small amount of connective tissue visible in the area
indicating the original defect within the cortical bone. No
macroscopic signs of inflammatory reactions were gener-
ally seen even at the early time points. However, this was
dependent on the implanted material [44]. Normally, the
radiographs taken with the faxitron machine revealed the
location and direction of the drill hole, although at later
time points (24 weeks) depending on the biomaterials
bone healing could be so far advanced that detection
proved to be difficult and only signs of intensive bone
remodelling indicated the original bone defects.
Preparation of the bone blocks after sacrifice: Note the rim  of adjacent bone (arrow) around the original bone defect  filled with biomaterial Figure 8
Preparation of the bone blocks after sacrifice: Note the rim 
of adjacent bone (arrow) around the original bone defect 
filled with biomaterial.
Postoperative lateromedial (Fig. 7a) and craniocaudal (Fig.  7b) radiograph of the distal part of the left femur after the  injection of two specific, but different biomaterials Figure 7
Postoperative lateromedial (Fig. 7a) and craniocaudal (Fig. 
7b) radiograph of the distal part of the left femur after the 
injection of two specific, but different biomaterials. While 
bone cement (Fig. 7b) reveals immediate radiodensity, a bio-
material based on hydrogel and without radiopacifier cannot 
be visualized immediately after surgery. If bone formation 
takes place over time, radiodensity will increase gradually.
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The bone samples could be easily embedded in acrylic
resin and in all instances the size of samples allowed the
preparation of non-decalcified histology sections for
ground and thin sections. Depending on the biomaterials
and stage of osseointegration or resorption the sectioning
of thin sections required great skill from our histology
technician. This was especially true for sections containing
calcium phosphate bone cements where the biomaterial
was brittle and if no bone replacement had taken place yet
in the early sections (2, 4 and 8 weeks) the material simply
disintegrated during sectioning. However, this hardly
occurred in the ground sections (30 – 40 µm). There, the
defect could be clearly distinguished from the surround-
ing bone. Thin sections allowed distinguishing cellular
events in all instances even if the bulk of biomaterial was
fallen off during sectioning since the immediately adja-
cent tissue could still always be evaluated (Fig. 11).
The time frame up to 6 months proved to be adequate for
this size of defect, since most of the biomaterials tested
were resorbed and replaced by new bone to at least two
thirds of the original bone defect within this period. The
same was true for the assessment of cellular events within
this given time point. Degradation mechanisms could be
easily followed at the interface between biomaterials and
host tissue. The early time points (2, 4 weeks) were help-
ful to test biocompatibility issues since the appearance of
foreign body or other mononuclear cells indicative of host
reaction to the material occurred mainly within this early
phase.
Discussion
The drill hole model in sheep as presented is well suited
to test biocompatibility issues regarding biodegradable
materials, but also to answer questions related to material
resorption, substitution with new bone or less functional
Microradiographs taken from two different biomaterial sam- ples: Microradiographs show the stage of calcification of the  bone after the application of bone enhancing materials (Fig.  10a) or both, remnants of bone cements based on calcium  phosphate and replacement by new bone (Fig. 10b) Figure 10
Microradiographs taken from two different biomaterial sam-
ples: Microradiographs show the stage of calcification of the 
bone after the application of bone enhancing materials (Fig. 
10a) or both, remnants of bone cements based on calcium 
phosphate and replacement by new bone (Fig. 10b).
a
b
Radiograph taken with the faxitron machine: The technique,  where the entire bone or bone samples already cut in blocks  are radiographed with the faxitron machine, allows the  assessment of bony changes, such as bone resorption (arrow  head) or bone sclerosis (arrow) as a means for biocompati- bility of the inserted biomaterials Figure 9
Radiograph taken with the faxitron machine: The technique, 
where the entire bone or bone samples already cut in blocks 
are radiographed with the faxitron machine, allows the 
assessment of bony changes, such as bone resorption (arrow 
head) or bone sclerosis (arrow) as a means for biocompati-
bility of the inserted biomaterials. In Fig. 9a an entire femur is 
shown (arrow: Bone-fixation device), whereas in Fig.9b only 
the original defect with a rim of adjacent bone is pictured.BMC Musculoskeletal Disorders 2006, 7:67 http://www.biomedcentral.com/1471-2474/7/67
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tissue such as fibrous tissue. The experimental model was
established in 70 sheep with a total of 560 drill holes for
materials to be tested in bone. Several advantages are per-
tinent to this well standardized animal model with ani-
mal welfare being one of the most important aspects,
closely followed by the possibility to translate results rel-
atively easy to humans without the necessity of additional
animal experiments related to biocompatibility ques-
tions.
The surgical technique requires a modified drill bit with a
flattened tip, solid anatomical knowledge and experience
of the surgeon. The small stab incisions and minimal
preparation of soft tissues to access the bone cortex, where
the drill hole will be placed, are part of the regimen of
minimally invasive surgery and thus, atraumatic tech-
The graph represents a drawing of a longitudinal section of  the proximal part of the femur Figure 12
The graph represents a drawing of a longitudinal section of 
the proximal part of the femur. The lines picture the area 
where cancellous bone can be found, but also the trajecto-
ries indicating the direction of the mechanical tension lines in 
the bone.
Histology samples: While ground sections (30–40 µm, sur- face stained with toluidine blue) are well suited for the  assessment of osseointegration, new bone formation, materi- als resorption and histomorphometrical measurement (Fig.  11a), thin sections allow assessing cellular reactions such as  degradation and elimination of biomaterials through macro- phages (Fig. 11b, arrow) or the appearance of foreign body  cells (Fig. 11c, arrow) Figure 11
Histology samples: While ground sections (30–40 µm, sur-
face stained with toluidine blue) are well suited for the 
assessment of osseointegration, new bone formation, materi-
als resorption and histomorphometrical measurement (Fig. 
11a), thin sections allow assessing cellular reactions such as 
degradation and elimination of biomaterials through macro-
phages (Fig. 11b, arrow) or the appearance of foreign body 
cells (Fig. 11c, arrow).
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nique including prevention of unnecessary suffering of
the animals.
The diligent and correct positioning of the limbs for sur-
gery turned out to be a decisive factor for positioning the
drill holes, especially for the distal humerus and femur.
This allows optimal positioning of the drill hole that
needs to be placed exactly as described in the surgical tech-
nique because of the quality of the brittle sheep bone. If
the drill holes are slightly misplaced spontaneous frac-
tures occur as described with the 4 animals with compli-
cations. The special structure and morphology of long
bones in sheep corresponds to the function and mechan-
ical load of the specific bone area [45]. This leads to a rel-
atively large area of cancellous bone with a thin cortex in
the metaphysis and epiphysis of the humerus and femur.
Here, the mechanical pressure can be transferred to the
cancellous network, while closer to the diaphysis this is
not possible any longer since there is only cortical bone
and fatty bone marrow to withstand the mechanical load
(Fig. 12). The relative large drill hole of 8 mm in relation
to the overall bone diameter obviously disturbs the ten-
sion lines of the bones significantly and gives rise to spiral
fissures and cracks along these so called trajectories. This
occurs even if only one cortex is drilled and is usually
associated with severely comminuted fractures. If the drill
holes are correctly placed within the metaphysis (proxi-
mal humerus and femur) or epiphysis (distal humerus
and femur) this complication can be avoided. Especially
in the distal humerus it may be better to stay away from
drilling the hole if in doubt whether the position is cor-
rectly chosen. When the method was performed correctly,
as described above, then there were no unforeseen frac-
tures. In 9 cases the drill bit slipped into the cranial pouch
of the elbow joint. To avoid spontaneous fractures, the
drilling was not repeated and no biomaterial was applied.
Since we only touched the joint but never penetrated any
important structures, it had no clinical implication such
as haematoma, pain or lameness.
Histology with non-decalcified bone sections proved to
be suitable to assess bone healing as well as the behaviour
of biodegradable materials. By sectioning the bone sam-
ples in midlength and perpendicular to the original drill
hole the stage and ratio of new bone formation versus
material resorption could be optimally visualized and cal-
culated at its most remote location. Since any biomaterial
used in bone finally will be replaced by creeping substitu-
tion [46] it may be safely assumed that if the centre and
middle of the original biomaterial is replaced with new
bone the rest of the original bone defect has already been
replaced and is already undergoing bone remodelling. If
deemed necessary serial sections can be prepared through-
out the entire original defect, although the extensive
workload and costs associated with preparing sections of
non-decalcified bone may prove inhibitive. The standard-
ized drill hole defect is well suited for histomorphometri-
cal measurements where an automatic software program
with the appropriately established "macro" allows the cal-
culation of area percentages of bone, remnants of bioma-
terials as well as replacement with fibrous tissue. Apart
from the overall percentage of each component the area
may be divided in rings facilitating the comparison of the
peripheral, middle and more central areas of the original
bone defect [43]. This is interesting especially if the rate of
resorption over time or between different biomaterials
should be compared (Fig. 13).
It is common belief that for ethical reasons small experi-
mental animals, such as mice, rats or rabbits, should be
used wherever possible. Another reason to turn to small
rodents is for economical aspects as rats and mice are
much less expensive and easier to maintain as sheep. Bio-
compatibility of novel materials is often tested in less
demanding animal models in the literature. Biological
materials implanted into soft tissue, for example intra-
muscularly [9,16,29] or subcutaneously [12,14,17,33]),
may answer questions pertaining to the local cellular and
humoral reaction, but not to the degree of new bone for-
mation, osteoinduction and -conduction. Even the local
cellular degradation mechanisms may be different in soft
and osseous tissue, since osteoclasts often involved in syn-
thetic hydroxyapatite-based bone materials, are only
present in bone but not subcutaneous or muscular tissues.
In addition, any material placed in soft tissue may elicit
the formation of a soft tissue capsule in an attempt to wall
it off. This reaction most likely has nothing in common
The picture shows the division in peripheral, middle and cen- tre area of the bone defect as may be necessary to compare  bone formation and biomaterials resorption over time or  between different materials Figure 13
The picture shows the division in peripheral, middle and cen-
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with a response related to biocompatibility, but could
also be a reaction to mechanical instability and different
stiffness and rigidity of soft tissue and the implanted bio-
material. In the author's judgement the subcutaneous and
intramuscular pouch model in rodents as introduced by
Urist et al [47,48] is a valuable animal model for hetero-
topic osteoinduction triggered by biomimetic substances,
but not for testing biocompatibility issues related to bone.
There are successful reports with drill holes used in rabbit
tibias [23,26] and rat femurs [11]. Rodents may require
less time and cost as well as less sophisticated surgery and
anaesthesia facilities. However, more animals per study
may be required due to limited anatomical space and size
of animals. Furthermore, bone metabolism is significantly
different with mostly faster bone remodelling. Positive
results in rodents may have to be repeated and verified in
larger species before human clinical trials can be initiated.
Because of the similarities with human bone metabolism
the results from sheep carry more authority than those
obtained small laboratory animals [34].
The drill hole model as presented here has additional
advantages. With this model it is possible to investigate
and compare the in vivo characteristics of up to eight dif-
ferent materials in one animal. Also it is possible to com-
pare more than one sample of the same material within
an animal but in different locations representing different
densities of cancellous bone. This is not just a question of
animal protection, but also adds the possibility to com-
pare directly the individual's reaction to various materials.
Last but not least, this model allows testing of biomateri-
als without other than the physiologic mechanical load,
which is in contrast to animal models that produced sin-
gle injection or implantation sites using osteotomy or
ostectomies [24,30,49]. These models may not be as suit-
able for biocompatibility testing of materials in bone as
the drill hole model, since it may be difficult to attribute
failures to material incompatibility or mechanical prob-
lems. Critical sized bone defects in long or cranial bones
are the next step once the biocompatibility of the material
has been established [31,32,50,51].
Conclusion
The drill hole model in sheep proves to be an excellent
animal model to test biocompatibility of biomaterials
that should be implanted in bone. Overall, it is a safe
model for the experienced surgeon, reduces suffering and
numbers of experimental animals and serves as an excel-
lent basis for testing the best materials in a more challeng-
ing animal model where mechanical properties play a role
such as in critical sized bone defects of long, maxillofacial
or cranial bone.
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